Phase 3 randomized trial comparing tebentafusp with investigator's choice in first line metastatic uveal melanoma Meeting Abstract
| Authors: | Piperno-Neumann, S.; Hassel, J. C.; Rutkowski, P.; Baurain, J. F.; Butler, M. O.; Schlaak, M.; Sullivan, R. J.; Ochsenreither, S.; Dummer, R.; Kirkwood, J. M.; Joshua, A. M.; Sacco, J. J.; Shoushtari, A. N.; Orloff, M.; Carvajal, R. D.; Hamid, O.; Abdullah, S. E.; Holland, C.; Goodall, H.; Nathan, P. |
| Abstract Title: | Phase 3 randomized trial comparing tebentafusp with investigator's choice in first line metastatic uveal melanoma |
| Meeting Title: | 112th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 81 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2021 Apr 10-15/May 17-21 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2021-07-01 |
| Language: | English |
| ACCESSION: | WOS:000680263501026 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.AM2021-CT002 |
| Notes: | Meeting Abstract: CT002 -- Due to Covid 19 pandemic, the conference was held virtually -- Source: Wos |
